Aprogen Pharmaceuticals Inc (003060) — Free Cash Flow Generation Index
Aprogen Pharmaceuticals Inc (003060) has a Free Cash Flow Generation Index of 0.13x as of December 2022. Free cash flow of ₩85.90 Million represents 0% of operating cash flow (₩676.93 Million). Explore Aprogen Pharmaceuticals Inc capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Aprogen Pharmaceuticals Inc Free Cash Flow Generation Index (2010–2022)
Historical FCF Generation Index trend for Aprogen Pharmaceuticals Inc across 7 annual periods. For the full cash flow conversion analysis, see Aprogen Pharmaceuticals Inc (003060) cash flow conversion.
Annual Free Cash Flow Generation for Aprogen Pharmaceuticals Inc (2010–2022)
Year-by-year Free Cash Flow Generation Index for Aprogen Pharmaceuticals Inc. Check Aprogen Pharmaceuticals Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.94x | ₩24.18 Billion | ₩25.73 Billion | ₩1.55 Billion | ▲ +14.0% |
| 2020 | 0.82x | ₩6.67 Billion | ₩8.09 Billion | ₩976.29 Million | ▲ +134.5% |
| 2019 | -2.39x | ₩-1.71 Billion | ₩713.73 Million | ₩2.13 Billion | ▼ -248.9% |
| 2018 | -0.69x | ₩-912.93 Million | ₩1.33 Billion | ₩1.01 Billion | ▼ -109.4% |
| 2016 | 7.27x | ₩3.27 Billion | ₩449.98 Million | ₩2.82 Billion | ▲ +86.0% |
| 2015 | 3.91x | ₩7.22 Billion | ₩1.85 Billion | ₩5.37 Billion | ▼ -92.3% |
| 2010 | 50.52x | ₩12.52 Billion | ₩247.92 Million | ₩12.28 Billion | — |